SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-222337
Filing Date
2012-05-09
Accepted
2012-05-09 16:57:04
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d345387d10q.htm 10-Q 601631
2 FORM OF INDEMNIFICATION AGREEMENT WITH CERTAIN DIRECTORS AND EXECUTIVE OFFICERS d345387dex101.htm EX-10.1 67660
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER REQUIRED UNDER RULE 13A-14(A) d345387dex311.htm EX-31.1 8604
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER REQUIRED UNDER RULE 13A-14(A) d345387dex312.htm EX-31.2 8455
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER d345387dex321.htm EX-32.1 5893
  Complete submission text file 0001193125-12-222337.txt   2307174

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avnr-20120331.xml EX-101.INS 283930
7 XBRL TAXONOMY EXTENSION SCHEMA avnr-20120331.xsd EX-101.SCH 13136
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avnr-20120331_cal.xml EX-101.CAL 31681
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avnr-20120331_lab.xml EX-101.LAB 115143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avnr-20120331_pre.xml EX-101.PRE 67265
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 12826517
SIC: 2834 Pharmaceutical Preparations